‘Paying Twice’: A Push for Affordable Prices for Taxpayer-Funded Drugs

The National Institutes of Health is helping to develop more cutting-edge drugs. But the agency says its mission doesn’t include evaluating prices, even when the drugs use breakthroughs it patented.

from NYT > Politics https://ift.tt/2kv51kN